In Section A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants is going to be enrolled at the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section https://abbv-744-in-the-treatment57801.blog2news.com/32551109/the-basic-principles-of-abbv-744-in-acute-myeloid-leukemia-aml